192 related articles for article (PubMed ID: 37081974)
1.
Fang X; Sun P; Dong Y; Huang Y; Lu JJ; Kong L
Front Oncol; 2023; 13():896142. PubMed ID: 37081974
[TBL] [Abstract][Full Text] [Related]
2. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
[TBL] [Abstract][Full Text] [Related]
3. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
4. Determining RBE for development of lung fibrosis induced by fractionated irradiation with carbon ions utilizing fibrosis index and high-LET BED model.
Zhou C; Jones B; Moustafa M; Yang B; Brons S; Cao L; Dai Y; Schwager C; Chen M; Jaekel O; Chen L; Debus J; Abdollahi A
Clin Transl Radiat Oncol; 2019 Jan; 14():25-32. PubMed ID: 30511024
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic cancer cell lines.
El Shafie RA; Habermehl D; Rieken S; Mairani A; Orschiedt L; Brons S; Haberer T; Weber KJ; Debus J; Combs SE
J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i113-9. PubMed ID: 23824114
[TBL] [Abstract][Full Text] [Related]
6. The relative biological effectiveness of carbon ion radiation therapy for early stage lung cancer.
Jeong J; Taasti VT; Jackson A; Deasy JO
Radiother Oncol; 2020 Dec; 153():265-271. PubMed ID: 32976878
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of photon, proton and carbon-ion radiation on the ecto-calreticulin exposure in various tumor cell lines.
Huang Y; Dong Y; Zhao J; Zhang L; Kong L; Lu JJ
Ann Transl Med; 2019 Oct; 7(20):542. PubMed ID: 31807524
[TBL] [Abstract][Full Text] [Related]
8. Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma.
Iijima M; Okonogi N; Nakajima NI; Morokoshi Y; Kanda H; Yamada T; Kobayashi Y; Banno K; Wakatsuki M; Yamada S; Kamada T; Aoki D; Hasegawa S
J Gynecol Oncol; 2020 Mar; 31(2):e19. PubMed ID: 31912675
[TBL] [Abstract][Full Text] [Related]
9. Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma.
Schnoell J; Stanisz I; Jank BJ; Stanek V; Schmid R; Brunner M; Heiduschka G; Kotowski U
Invest New Drugs; 2022 Apr; 40(2):224-231. PubMed ID: 34613571
[TBL] [Abstract][Full Text] [Related]
10. Relative Biological Effectiveness of Carbon Ions for Head-and-Neck Squamous Cell Carcinomas According to Human Papillomavirus Status.
Osu N; Kobayashi D; Shirai K; Musha A; Sato H; Hirota Y; Shibata A; Oike T; Ohno T
J Pers Med; 2020 Jul; 10(3):. PubMed ID: 32722522
[TBL] [Abstract][Full Text] [Related]
11. Carbon ion irradiation withstands cancer stem cells' migration/invasion process in Head and Neck Squamous Cell Carcinoma (HNSCC).
Moncharmont C; Guy JB; Wozny AS; Gilormini M; Battiston-Montagne P; Ardail D; Beuve M; Alphonse G; Simoëns X; Rancoule C; Rodriguez-Lafrasse C; Magné N
Oncotarget; 2016 Jul; 7(30):47738-47749. PubMed ID: 27374096
[TBL] [Abstract][Full Text] [Related]
12. Carbon Ion Beam Boost Irradiation in Malignant Tumors of the Nasal Vestibule and the Anterior Nasal Cavity as an Organ-Preserving Therapy.
Eberle F; Engenhart-Cabillic R; Schymalla MM; Dumke C; Schötz U; Subtil FSB; Baumann KS; Stuck BA; Langer C; Jensen AD; Hauswald H; Lautenschläger S
Front Oncol; 2022; 12():814082. PubMed ID: 35242709
[TBL] [Abstract][Full Text] [Related]
13. Robustness of carbon-ion radiotherapy against DNA damage repair associated radiosensitivity variation based on a biophysical model.
Liew H; Tessonnier T; Mein S; Magro G; Glimelius L; Coniavitis E; Held T; Haberer T; Abdollahi A; Debus J; Dokic I; Mairani A
Med Phys; 2024 May; 51(5):3782-3795. PubMed ID: 38569067
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro.
Schlaich F; Brons S; Haberer T; Debus J; Combs SE; Weber KJ
Radiat Oncol; 2013 Nov; 8():260. PubMed ID: 24192264
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of Re-irradiation using carbon ions for recurrent head and neck malignancies after carbon-ion radiotherapy.
Hayashi K; Koto M; Ikawa H; Hagiwara Y; Tsuji H; Ogawa K; Kamada T
Radiother Oncol; 2019 Jul; 136():148-153. PubMed ID: 31015117
[TBL] [Abstract][Full Text] [Related]
16. FGFR Signaling as a Candidate Therapeutic Target for Cancers Resistant to Carbon Ion Radiotherapy.
Darwis NDM; Nachankar A; Sasaki Y; Matsui T; Noda SE; Murata K; Tamaki T; Ando K; Okonogi N; Shiba S; Irie D; Kaminuma T; Kumazawa T; Anakura M; Yamashita S; Hirakawa T; Kakoti S; Hirota Y; Tokino T; Iwase A; Ohno T; Shibata A; Oike T; Nakano T
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540114
[TBL] [Abstract][Full Text] [Related]
17. HPV-positive HNSCC cell lines show strongly enhanced radiosensitivity after photon but not after carbon ion irradiation.
Lerch S; Berthold S; Ziemann F; Dreffke K; Subtil FSB; Senger Y; Jensen A; Engenhart-Cabillic R; Dikomey E; Wittig A; Eberle F; Schötz U
Radiother Oncol; 2020 Oct; 151():134-140. PubMed ID: 32717362
[TBL] [Abstract][Full Text] [Related]
18. [Present status of carbon ion radiotherapy for malignant tumors].
Sugahara S; Kamada T
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1795-800. PubMed ID: 19920380
[TBL] [Abstract][Full Text] [Related]
19. Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model.
Wang W; Li P; Sheng Y; Huang Z; Zhao J; Hong Z; Shahnazi K; Jiang GL; Zhang Q
Radiat Oncol; 2021 Apr; 16(1):72. PubMed ID: 33849589
[TBL] [Abstract][Full Text] [Related]
20. The antitumor drug F14512 enhances cisplatin and ionizing radiation effects in head and neck squamous carcinoma cell lines.
Mouawad F; Gros A; Rysman B; Bal-Mahieu C; Bertheau C; Horn S; Sarrazin T; Lartigau E; Chevalier D; Bailly C; Lansiaux A; Meignan S
Oral Oncol; 2014 Feb; 50(2):113-9. PubMed ID: 24290982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
